Drug recall · August 20, 2014
Lite Fit USA recall
Why: Marketed Without an Approved NDA/ANDA: Bacai, Inc. DBA Ky Duyen House is voluntarily recalling Lite Fit USA, lot 13165, due to undeclared sibutramine, making it an unapproved new drug.
Class I: a reasonable chance the product could cause serious harm or death.
The recall
- Product
Lite Fit USA, For Men & Women, Extreme Fat Burner, Suppresses Appetite, Boosts Metabolism, Limits Fat Absorption, Increases Energy, Prevents lipid formation by limiting fat absorption 30 pills /Bottle, Distributed by: Bacai, INC. www.litefitusa.com
- Lots / codes
Lot #13165; Exp. 05/17
- Quantity
- 14,040 softgel capsules
- Company
- Bacai Inc. Dba Ky Duyen House, Fountain Valley, CA
- Distribution
- Worldwide via internet sales
- Initiated
- April 30, 2014 · Voluntary: Firm initiated
- Classified
- August 8, 2014
- Reported
- August 20, 2014
- Ended
- February 10, 2015
- How notified
- Letter
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.